Simulations Plus: Benefiting From FDA Modernization And AI [Seeking Alpha]
Simulations Plus, Inc. (SLP)
Last simulations plus, inc. earnings: 4/9 04:35 pm
Check Earnings Report
US:NASDAQ Investor Relations:
simulations-plus.com/software/overview
Company Research
Source: Seeking Alpha
SLP's diverse software portfolio, including GastroPlus and ADMET Predictor, and consulting services position it as a comprehensive partner in biotech development. Favorable regulatory changes by the FDA towards AI and non-animal testing methods boost SLP's market potential, despite its current high valuation. SLP's long-term outlook remains strong due to its innovative approach and the growing adoption of AI in drug testing, making it a "Buy" for long-term investors. BlackJack3D Simulations Plus, Inc. ( NASDAQ: SLP ) is a software company that delivers AI-based modeling and simulation tools. These types of solutions are particularly helpful for accelerating pharmaceutical research for drug discovery and optimization. SLP uses pharmacology data to train its modeling Recommended For You Comments Recommended For You About SLP Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
SLP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLP alerts
High impacting Simulations Plus, Inc. news events
Weekly update
A roundup of the hottest topics
SLP
News
- Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date [Yahoo! Finance]Yahoo! Finance
- Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call DateBusiness Wire
- When Should You Buy Simulations Plus, Inc. (NASDAQ:SLP)? [Yahoo! Finance]Yahoo! Finance
- Simulations Plus Positioned to Capitalize on FDA’s Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed SolutionsBusiness Wire
- Simulations Plus: Buying On Long-Term Silico Drug-Development [Seeking Alpha]Seeking Alpha
SLP
Earnings
- 12/1/25 - In-Line
SLP
Sec Filings
- 12/8/25 - Form 8-K
- 12/2/25 - Form 4
- 12/1/25 - Form 144
- SLP's page on the SEC website